AJP - Endo Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab (May 27, 2004). doi:10.1152/ajpendo.00110.2004
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
287/3/E566    most recent
00110.2004v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Iida, K.
Right arrow Articles by Thorner, M. O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Iida, K.
Right arrow Articles by Thorner, M. O.
Submitted on March 5, 2004
Accepted on May 25, 2004

Regulation of full-length and truncated growth hormone (GH) receptor by GH in tissues of lit/lit or bovine GH transgenic mice

Keiji Iida1*, Juan P. del Rincon1, Dong-Sun Kim1, Emina Itoh1, Karen T. Coschigano2, John J. Kopchick3, and Michael O. Thorner1

1 Division of Endocrinology and Metabolism, Department of Internal Medicine, University of Virginia, Charlottesville, Virginia, USA
2 Edison Biotechnology Institute, Ohio University, Athens, Ohio, USA
3 Edison Biotechnology Institute, Ohio University, Athens, Ohio, USA; Department of Biomedical Sciences, College of Osteopathic Medicine, Ohio University, Athens, Ohio, USA

* To whom correspondence should be addressed. E-mail: iidak2{at}aol.com.

Two truncated isoforms of growth hormone (GH) receptor (GHR) were identified in mice and in humans. The proteins encoded by these isoforms lack most of the intracellular domain of the GHR and inhibit GH action in a dominant negative fashion. We have quantified the mRNAs encoding the GHR isoforms in mouse tissues using real-time RT-PCR and examined the effect of GH excess or deficiency on regulation of mRNA levels of the GHR isoforms in vivo. In the liver, the truncated GHR mRNAs (mGHR-282 and -280) were 0.5% and less than 0.1% the level of full-length GHR (mGHR-fl). In skeletal muscle, the values were 2-3% and 0.1-0.5% of mGHR-fl, respectively and in subcutaneous fat, the values were 3-5% and 0.1-0.5% of mGHR-fl, respectively. The bGH transgenic mice showed a significant increase of mGHR-fl in liver but a significant decrease in skeletal muscle with no difference in subcutaneous fat when compared with control mice. The lit/lit mice showed a significant decrease of mGHR-fl in liver, no difference of mGHR-fl in muscle, and a significant increase of mGHR-fl in subcutaneous fat when compared with lit/+ mice. The mRNA of mGHR-282 was regulated in parallel with mGHR-fl in all tissues of all mice examined whereas that of mGHR-280 was not changed either in GH excess or deficient states. In conclusion, two truncated isoforms of GHR mRNAs were detected in liver, skeletal muscle, and subcutaneous fat of mice. The GHR-tr/GHR-fl mRNA ratio was tissue-specific and not affected by chronic excess or deficiency of GH.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2004 by the American Physiological Society.